Calls Purchased on Geron Corp. (GERN)
Shares of Geron Corp. (NASDAQ: GERN) are higher on the session by 1.53%, currently trading at $4.64. The stock has been moving largely lower over the past six months and is currently trading in a technical downtrend.
Options traders are buying calls on the name today, though, betting that the stock may be at a short-term bottom. Though action has been in small lots, call volume is currently running at 2.43x the daily average. Traders are focusing on the $5.00 and $7.50 strikes in multiple months.
Geron Corporation is a biopharmaceutical company that is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.